TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 131 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $4,475,000 | -1.9% | 94,321 | -24.3% | 0.52% | -0.6% |
| Q1 2015 | $4,563,000 | -32.5% | 124,525 | -26.9% | 0.53% | -44.1% |
| Q4 2014 | $6,760,000 | +122.1% | 170,240 | +11.6% | 0.94% | +52.3% |
| Q3 2014 | $3,044,000 | +76.6% | 152,595 | +19.7% | 0.62% | +100.3% |
| Q4 2013 | $1,724,000 | +18.1% | 127,495 | -0.6% | 0.31% | +6.2% |
| Q3 2013 | $1,460,000 | – | 128,312 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |